Categories

Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine Hydrochloride Injection Due to Cross-Contamination of Lidocaine

Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial. Fresenius Kabi initiated this recall due to the possibility of a trace amount of lidocaine present in these two lots and our investig

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-nationwide-recall-two-lots-dexmedetomidine-hydrochloride-injection

 
Categories

FDA Reminds Owners and Operators About Repair and Maintenance of Tanning Beds and Booths: FDA Safety Communication

The FDA is reminding owners and operators about repair and maintenance of tanning beds and booths. Owners and operators of tanning beds and booths should perform maintenance recommended by product manufacturers to reduce risk of smoke and fire.

http://www.fda.gov/medical-devices/safety-communications/fda-reminds-owners-and-operators-about-repair-and-maintenance-tanning-beds-and-booths-fda-safety